Supplementary Figure Legends 1-5 from Mre11-Dependent Degradation of Stalled DNA Replication Forks Is Prevented by BRCA2 and PARP1

Songmin Ying,Freddie C. Hamdy,Thomas Helleday

DOI: https://doi.org/10.1158/0008-5472.22391598

2023-01-01

Abstract:PDF file - 24K

What problem does this paper attempt to address?

Supplementary Figure 4 from Mre11-Dependent Degradation of Stalled DNA Replication Forks Is Prevented by BRCA2 and PARP1

Songmin Ying,Freddie C. Hamdy,Thomas Helleday

DOI: https://doi.org/10.1158/0008-5472.22391604

2023-01-01

Abstract:PDF file - 34K, Reduction of ssDNA by inhibition of Mre11
Supplementary Figure 5 from Mre11-Dependent Degradation of Stalled DNA Replication Forks Is Prevented by BRCA2 and PARP1

Songmin Ying,Freddie C. Hamdy,Thomas Helleday

DOI: https://doi.org/10.1158/0008-5472.22391601

2023-01-01

Abstract:PDF file - 79K, Stalled replication forks are protected from degradation in PARP inhibitor-resistant cells
Supplementary Figure 2 from Mre11-Dependent Degradation of Stalled DNA Replication Forks is Prevented by BRCA2 and PARP1

Songmin Ying,Freddie C. Hamdy,Thomas Helleday

DOI: https://doi.org/10.1158/0008-5472.22391610.v1

2023-01-01

Abstract:PDF file - 34K, Mre11 foci formation in BRCA2 deficient cells is independent of NHEJ
Supplementary Figure Legends from DNA-PKcs and PARP1 Bind to Unresected Stalled DNA Replication Forks Where They Recruit XRCC1 to Mediate Repair

Songmin Ying,Zhihui Chen,Annette L. Medhurst,Jessica A. Neal,Zhengqiang Bao,Oliver Mortusewicz,Joanna F. McGouran,Xiaomin Song,Huahao Shen,Freddie C. Hamdy,Benedikt M. Kessler,Katheryn Meek,Thomas Helleday

DOI: https://doi.org/10.1158/0008-5472.22411764.v1

2023-01-01

Abstract:Supplementary Figure Legends
Supplementary Figure Legends from Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells

Rajat Bhattacharya,Xiang-Cang Ye,Rui Wang,Xia Ling,Madonna McManus,Fan,Delphine Boulbes,Lee M. Ellis

DOI: https://doi.org/10.1158/0008-5472.22407995.v1

2023-01-01

Abstract:Legends for Supplementary Figures S1-S12.
Supplementary Figure 1 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Lauren Averett Byers,Jing Wang,Monique B. Nilsson,Junya Fujimoto,Pierre Saintigny,John Yordy,Uma Giri,Michael Peyton,You Hong Fan,Lixia Diao,Fatemeh Masrorpour,Li Shen,Wenbin Liu,Boris Duchemann,Praveen Tumula,Vikas Bhardwaj,James Welsh,Stephanie Weber,Bonnie S. Glisson,Neda Kalhor,Ignacio I. Wistuba,Luc Girard,Scott M. Lippman,Gordon B. Mills,Kevin R. Coombes,John N. Weinstein,John D. Minna,John V. Heymach

DOI: https://doi.org/10.1158/2159-8290.22528440.v1

2023-01-01

Abstract:PDF file, 125K, Western blot of total PARP1.
Supplementary Figure 3 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Lauren A. Byers,Jing Wang,Monique B. Nilsson,Junya Fujimoto,Pierre Saintigny,John S. Yordy,Uma Giri,Michael Peyton,You Hong Fan,Lixia Diao,Fatemeh Masrorpour,Li Shen,Wenbin Liu,Boris Duchemann,Praveen K. Tumula,Vikas Bhardwaj,James Welsh,Stephanie Weber,Bonnie S. Glisson,Neda Kalhor,Ignacio I. Wistuba,Luc Girard,Scott M. Lippman,Gordon B. Mills,Kevin R. Coombes,John N. Weinstein,John D. Minna,John V. Heymach

DOI: https://doi.org/10.1158/2159-8290.22528434.v1

2023-01-01

Abstract:PDF file, 81K, Effect of PARP inhibition in combination with standard chemotherapy.
Supplementary Figure Legends from RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer

Yajing Liu,Monika L. Burness,Rachel Martin-Trevino,Joey Guy,Shoumei Bai,Ramdane Harouaka,Michael Brooks,Shang Li,Alex Fox,Tahra Luther,April Davis,Trenton L. Baker,Justin A. Colacino,Shawn G. Clouthier,Zhi‐Ming Shao,Max S. Wicha,Suling Liu

DOI: https://doi.org/10.1158/1078-0432.22460774.v1

2023-01-01

Abstract:Supplementary figures 1-8 legends
Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Jiahui Mou,Meijun Huang,Feifei Wang,Xiaoding Xu,Hanqi Xie,Henglei Lu,Mingyang Li,Yu Li,Weiwen Kong,Jing Chen,Ying Xiao,Yiding Chen,Chaochen Wang,Jin Ren

DOI: https://doi.org/10.1158/1541-7786.22527890

2023-01-01

Abstract:Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis
Supplementary Figure Legends 1-6, Methods from Pivotal Role of Reduced let-7g Expression in Breast Cancer Invasion and Metastasis

Pengxu Qian,Zehua Zuo,Zhengsheng Wu,Xianyi Meng,Gaopeng Li,Zhengzhou Wu,Weijie Zhang,Sheng Tan,Vijay Pandey,Yandan Yao,Puyue Wang,Liqing Zhao,Jun Wang,Qiang Wu,Erwei Song,Peter E. Lobie,Zhinan Yin,Tao Zhu

DOI: https://doi.org/10.1158/0008-5472.22391054

2023-01-01

Abstract:PDF file - 214K
Supplementary Figure Legend from Synergistic Activities of MET/RON Inhibitor BMS-777607 and Mtor Inhibitor AZD8055 to Polyploid Cells Derived from Pancreatic Cancer and Cancer Stem Cells

Junying Zeng,Sharad Sharma,Yong‐Qing Zhou,Hang‐Ping Yao,Xing Hu,Ruiwen Zhang,Ming-Hai Wang

DOI: https://doi.org/10.1158/1535-7163.22503690

2023-01-01

Abstract:PDF - 71K, Legends for Supplementary Figures 1 through 5.
BRCA2 associates with MCM10 to suppress PRIMPOL-mediated repriming and single-stranded gap formation after DNA damage

Zhihua Kang,Pan Fu,Allen L. Alcivar,Haiqing Fu,Christophe Redon,Tzeh Keong Foo,Yamei Zuo,Caiyong Ye,Ryan Baxley,Advaitha Madireddy,Remi Buisson,Anja-Katrin Bielinsky,Lee Zou,Zhiyuan Shen,Mirit I. Aladjem,Bing Xia

DOI: https://doi.org/10.1038/s41467-021-26227-6

IF: 16.6

2021-01-01

Nature Communications

Abstract:The BRCA2 tumor suppressor protects genome integrity by promoting homologous recombination-based repair of DNA breaks, stability of stalled DNA replication forks and DNA damage-induced cell cycle checkpoints. BRCA2 deficient cells display the radio-resistant DNA synthesis (RDS) phenotype, however the mechanism has remained elusive. Here we show that cells without BRCA2 are unable to sufficiently restrain DNA replication fork progression after DNA damage, and the underrestrained fork progression is due primarily to Primase-Polymerase (PRIMPOL)-mediated repriming of DNA synthesis downstream of lesions, leaving behind single-stranded DNA gaps. Moreover, we find that BRCA2 associates with the essential DNA replication factor MCM10 and this association suppresses PRIMPOL-mediated repriming and ssDNA gap formation, while having no impact on the stability of stalled replication forks. Our findings establish an important function for BRCA2, provide insights into replication fork control during the DNA damage response, and may have implications in tumor suppression and therapy response.
A RAD18-UBC13-PALB2-RNF168 axis mediates replication fork recovery in BRCA1-deficient cancer cells

Emily Cybulla,Sierra Wallace,Alice Meroni,Jessica Jackson,Sumedha Agashe,Mithila Tennakoon,Mangsi Limbu,Annabel Quinet,Elena Lomonosova,Hollie Noia,Stephanie Tirman,Matthew Wood,Delphine Lemacon,Katherine Fuh,Lee Zou,Alessandro Vindigni

DOI: https://doi.org/10.1093/nar/gkae563

2024-08-27

Abstract:BRCA1/2 proteins function in genome stability by promoting repair of double-stranded DNA breaks through homologous recombination and by protecting stalled replication forks from nucleolytic degradation. In BRCA1/2-deficient cancer cells, extensively degraded replication forks can be rescued through distinct fork recovery mechanisms that also promote cell survival. Here, we identified a novel pathway mediated by the E3 ubiquitin ligase RAD18, the E2-conjugating enzyme UBC13, the recombination factor PALB2, the E3 ubiquitin ligase RNF168 and PCNA ubiquitination that promotes fork recovery in BRCA1- but not BRCA2-deficient cells. We show that this pathway does not promote fork recovery by preventing replication fork reversal and degradation in BRCA1-deficient cells. We propose a mechanism whereby the RAD18-UBC13-PALB2-RNF168 axis facilitates resumption of DNA synthesis by promoting re-annealing of the complementary single-stranded template strands of the extensively degraded forks, thereby allowing re-establishment of a functional replication fork. We also provide preliminary evidence for the potential clinical relevance of this novel fork recovery pathway in BRCA1-mutated cancers, as RAD18 is over-expressed in BRCA1-deficient cancers, and RAD18 loss compromises cell viability in BRCA1-deficient cancer cells.
Supplementary Fig Legends from Chk1 and Chk2 Are Differentially Involved in Homologous Recombination Repair and Cell Cycle Arrest in Response to DNA Double-Strand Breaks Induced by Camptothecins

Min Huang,Ze-Hong Miao,Hong Zhu,Yu-Jun Cai,Wei Lu,Jian Ding

DOI: https://doi.org/10.1158/1535-7163.22484645.v1

2008-01-01

Molecular Cancer Therapeutics

Abstract:Supplementary Fig Legends from Chk1 and Chk2 are differentially involved in homologous recombination repair and cell cycle arrest in response to DNA double-strand breaks induced by camptothecins
Supplementary Figure Legends from Eif4b Phosphorylation by Pim Kinases Plays a Critical Role in Cellular Transformation by Abl Oncogenes

Jianling Yang,Jun Wang,Ke Chen,Guijie Guo,Ruijiao Xi,Paul B. Rothman,Douglas Whitten,Lianfeng Zhang,Shile Huang,Ji-Long Chen

DOI: https://doi.org/10.1158/0008-5472.22398183

2023-01-01

Abstract:PDF - 32K, Legend for Supplementary Figures S1-S5.
Supplemental Figures 1-7 from 14-3-3σ Contributes to Radioresistance by Regulating DNA Repair and Cell Cycle Via PARP1 and CHK2

Yifan Chen,Zhaomin Li,Dong Zhao,Jenny Beebe,Ke Yang,Liwu Fu,Jian‐Ting Zhang

DOI: https://doi.org/10.1158/1541-7786.22515376

2023-01-01

Abstract:Figure S1. 14-3-3Ïƒ contributes to IR resistance. Figure S2. 14-3-3Ïƒ contributes to IR resistance in H1299 cells. Figure S3. 14-3-3Ïƒ modulates IR-induced Î³-H2AX in H1299 cells. Figure S4. 14-3-3Ïƒ promotes NHEJ but not HR repair of DSBs. Figure S5. Role of PARP1 in DNA-PKcs recruitment. Figure S6. 14-3-3Ïƒ regulation of Chk2 expression in H1299 cells. Figure S7. PARP1 regulates Chk2 expression but not vice versa.
The underlying mechanism for the PARP and BRCA synthetic lethality: Clearing up the misunderstandings

Thomas Helleday

DOI: https://doi.org/10.1016/j.molonc.2011.07.001

2011-07-22

Molecular Oncology

Abstract:Poly (ADP‐ribose) polymerase (PARP) inhibitors effectively kill tumours defective in the BRCA1 or BRCA2 genes through the concept of synthetic lethality. It is suggested that PARP inhibitors cause an increase in DNA single‐strand breaks (SSBs), which are converted during replication to irreparable toxic DNA double‐strand breaks (DSBs) in BRCA1/2 defective cells. There are a number of recent reports challenging this model. Here, alternative models that are not mutually exclusive are presented to explain the synthetic lethality between BRCA1/2 and PARP inhibitors. One such model proposes that PARP inhibition causes PARP‐1 to be trapped onto DNA repair intermediates, especially during base excision repair. This may in turn cause obstruction to replication forks, which require BRCA‐dependent homologous recombination to be resolved. In another model, PARP is directly involved in catalysing replication repair in a distinct pathway from homologous recombination. Experimental evidence supporting these novel models to explain the PARP‐BRCA synthetic lethality are discussed.

oncology
Supplementary Figures from RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer

Yajing Liu,Monika L. Burness,Rachel Martin-Trevino,Joey Guy,Shoumei Bai,Ramdane Harouaka,Michael Brooks,Shang Li,Alex Fox,Tahra Luther,April Davis,Trenton L. Baker,Justin A. Colacino,Shawn G. Clouthier,Zhi‐Ming Shao,Max S. Wicha,Suling Liu

DOI: https://doi.org/10.1158/1078-0432.22460777.v1

2023-01-01

Abstract:Supplementary Figure S1. BRCA1 mutation confirmation and RAD51 gene expression in SUM149 cells. Supplementary Figure S2. RAD51 foci is associated with CSC population of BRCA1-mutant TNBC cells and effect of long-term PARP inhibition on RAD51. Supplementary Figure S3: Knockdown of RAD51 prevents foci formation in SUM149 and SUM159 cells. Supplementary Figure S4. The effect of RAD51 KD on TNBC viable cell count, CSCs, and cell cycle. Supplementary Figure S5. RAD51 KD sensitizes TNBC CSCs to PARPi. Supplementary Figure S6. Efficiency of RAD51 shRNA knockdown with additional shRNA vectors. Supplementary Figure S7. Knocking down RAD51 with two additional shRNA vectors also sensitizes CSCs to PARPi. Supplementary Figure S8. "Physiologic" RAD51 knockdown decreases cancer stem cells in SUM149 cells.
The RBBP6/ZBTB38/MCM10 axis regulates DNA replication and common fragile site stability.

Benoit Miotto,Moredreck Chibi,Ping Xie,Stéphane Koundrioukoff,Hanlie Moolman-Smook,David Pugh,Michelle Debatisse,Fuchu He,Lingqiang Zhang,Pierre-Antoine Defossez

DOI: https://doi.org/10.1016/j.celrep.2014.03.030

IF: 8.8

2014-01-01

Cell Reports

Abstract:Faithful DNA replication is essential for the maintenance of genome integrity. Incomplete genome replication leads to DNA breaks and chromosomal rearrangements, which are causal factors in cancer and other human diseases. Despite their importance, the molecular mechanisms that control human genome stability are incompletely understood. Here, we report a pathway that is required for human genome replication and stability. This pathway has three components: an E3 ubiquitin ligase, a transcriptional repressor, and a replication protein. The E3 ubiquitin ligase RBBP6 ubiquitinates and destabilizes the transcriptional repressor ZBTB38. This repressor negatively regulates transcription and levels of the MCM10 replication factor on chromatin. Cells lacking RBBP6 experience reduced replication fork progression and increased damage at common fragile sites due to ZBTB38 accumulation and MCM10 downregulation. Our results uncover a pathway that ensures genome-wide DNA replication and chromosomal stability.
Supplementary Figure Legends 1-10 from Proteasome Inhibition Causes Regression of Leukemia and Abrogates BCR-ABL–Induced Evasion of Apoptosis in Part Through Regulation of Forkhead Tumor Suppressors

Zainab Jagani,Keli Song,Jeffery L. Kutok,M. Rajan Dewar,Armelle Melet,Tanya Santos,Alexandra R. Grassian,Saghi Ghaffari,Catherine J. Wu,Ruibao Ren,Heather Yeckes Rodin,Kenneth G. Miller,Roya Khosravi‐Far

DOI: https://doi.org/10.1158/0008-5472.22378412

2023-01-01

Abstract:Supplementary Figure Legends 1-10 from Proteasome Inhibition Causes Regression of Leukemia and Abrogates BCR-ABL–Induced Evasion of Apoptosis in Part through Regulation of Forkhead Tumor Suppressors

Supplementary Figure Legends 1-5 from Mre11-Dependent Degradation of Stalled DNA Replication Forks Is Prevented by BRCA2 and PARP1

Supplementary Figure 4 from Mre11-Dependent Degradation of Stalled DNA Replication Forks Is Prevented by BRCA2 and PARP1

Supplementary Figure 5 from Mre11-Dependent Degradation of Stalled DNA Replication Forks Is Prevented by BRCA2 and PARP1

Supplementary Figure 2 from Mre11-Dependent Degradation of Stalled DNA Replication Forks is Prevented by BRCA2 and PARP1

Supplementary Figure Legends from DNA-PKcs and PARP1 Bind to Unresected Stalled DNA Replication Forks Where They Recruit XRCC1 to Mediate Repair

Supplementary Figure Legends from Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells

Supplementary Figure 1 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Supplementary Figure 3 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Supplementary Figure Legends from RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer

Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Supplementary Figure Legends 1-6, Methods from Pivotal Role of Reduced &lt;i&gt;let-7g&lt;/i&gt; Expression in Breast Cancer Invasion and Metastasis

Supplementary Figure Legend from Synergistic Activities of MET/RON Inhibitor BMS-777607 and Mtor Inhibitor AZD8055 to Polyploid Cells Derived from Pancreatic Cancer and Cancer Stem Cells

BRCA2 associates with MCM10 to suppress PRIMPOL-mediated repriming and single-stranded gap formation after DNA damage

A RAD18-UBC13-PALB2-RNF168 axis mediates replication fork recovery in BRCA1-deficient cancer cells

Supplementary Fig Legends from Chk1 and Chk2 Are Differentially Involved in Homologous Recombination Repair and Cell Cycle Arrest in Response to DNA Double-Strand Breaks Induced by Camptothecins

Supplementary Figure Legends from Eif4b Phosphorylation by Pim Kinases Plays a Critical Role in Cellular Transformation by Abl Oncogenes

Supplemental Figures 1-7 from 14-3-3σ Contributes to Radioresistance by Regulating DNA Repair and Cell Cycle Via PARP1 and CHK2

The underlying mechanism for the PARP and BRCA synthetic lethality: Clearing up the misunderstandings

Supplementary Figures from RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer

The RBBP6/ZBTB38/MCM10 axis regulates DNA replication and common fragile site stability.

Supplementary Figure Legends 1-10 from Proteasome Inhibition Causes Regression of Leukemia and Abrogates BCR-ABL–Induced Evasion of Apoptosis in Part Through Regulation of Forkhead Tumor Suppressors

Supplementary Figure Legends 1-6, Methods from Pivotal Role of Reduced <i>let-7g</i> Expression in Breast Cancer Invasion and Metastasis